Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
The rising impact of angiogenesis research
Arjan W Griffioen1, Andrew C Dudley2
1Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. a.griffioen@amsterdamumc.nl.
Abstract:
While inhibiting pathological angiogenesis has been long associated with the field of oncology, recent advances in angiogenesis research have impacted the progress of disease treatment for additional non-malignant diseases or chronic conditions in the fields of ophthalmology, cardiology, and gynecology. Moreover, stimulators of angiogenesis find application in ischemic diseases, while inhibitors of angiogenesis are being used to limit blood vessel formation, but in judicious ways that modify or "reprogram" the vasculature as a reinforcement for immunotherapy. We have noticed an increasing impact, as evidenced by increases in the total number of citations, in the literature surrounding the angiogenesis field suggesting that targeting angiogenesis per se is well established as a tractable approach for therapy in diverse conditions.
Insights
Targeting angiogenesis, the formation of new blood vessels, is crucial for treating cancer and other non-malignant diseases like ischemic conditions. Recent research shows reprogramming vasculature enhances immunotherapy, highlighting angiogenesis
Area of Science:
- * Angiogenesis research extends beyond oncology to non-malignant diseases.
- * Therapeutic applications span ophthalmology, cardiology, and gynecology.
Background:
- * Inhibiting pathological angiogenesis is key in oncology.
- * Stimulators of angiogenesis treat ischemic diseases.
- * Inhibitors are used judiciously to reprogram vasculature for immunotherapy.
Discussion:
- * Angiogenesis targeting is a well-established therapeutic approach.
- * Increasing citations reflect the growing impact of angiogenesis research.
- * Diverse conditions benefit from modulating blood vessel formation.
Key Insights:
- * Angiogenesis research has expanded to non-malignant conditions.
- * Vascular reprogramming is a novel strategy for immunotherapy enhancement.
- * Targeting angiogenesis offers a tractable approach for various diseases.
Outlook:
- * Continued exploration of angiogenesis modulators for diverse therapeutic areas.
- * Integration of angiogenesis strategies with immunotherapy.
- * Further research into reprogramming vasculature for improved treatment outcomes.
More Related Videos
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Overview of Cell-Matrix Interactions

